{"version":"1.0","provider_name":"Scl\u00e9rodermie Qu\u00e9bec","provider_url":"https:\/\/sclerodermie.ca\/en\/","author_name":"Guillaume Baril","author_url":"https:\/\/sclerodermie.ca\/en\/author\/guillaume\/","title":"Eight Quarter Report - May 2019 - Scl\u00e9rodermie Qu\u00e9bec","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"44Gdy3qOmY\"><a href=\"https:\/\/sclerodermie.ca\/en\/eight-quarter-report-may-2019\/\">Eight Quarter Report &#8211; May 2019<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/sclerodermie.ca\/en\/eight-quarter-report-may-2019\/embed\/#?secret=44Gdy3qOmY\" width=\"600\" height=\"338\" title=\"&#8220;Eight Quarter Report &#8211; May 2019&#8221; &#8212; Scl\u00e9rodermie Qu\u00e9bec\" data-secret=\"44Gdy3qOmY\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/sclerodermie.ca\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"Eighth Quarter Report &#8211; May 2019 &nbsp; This Project is a hypothesis-generating study for the control of lung damage in patients with idiopathic pulmonary fibrosis (IPF) and both lung and skin damage in systemic scleroderma (SSc) patients either with or without interstitial lung disease (ILD). Enrolment of SSc patients with and without ILD to provide [&hellip;]"}